Redeye is positive to Bredband2’s acquisition of Bredbandsson, adding about 0.
Group net sales was EUR 31.7m in Q2 (Nordea est. EUR 30.
Redeye provides a research update following the Q2 2024 report from Precise Biometrics.
Redeye states that BeammWave’s Q2 report aligned with expectations.
Björn Borg (”Björn Borg” or ”the Company”) published its Q2 report for 2024 on the 16th of August, 2...
Investment management to be main earnings contributor in Q2 Continued weak market activity makes us ...
Redeye remains confident on the case as Railcare showed surprisingly strong sales growth of 24% in Q...
Redeye states BeammWave's Q2 report aligned with expectations.
Redeye gives its initial comments on the Q2 2024 report from Precise Biometrics.
11% adj. EBITA miss but improvement already in Q3 '24e adj.
European recovery needed in H2 to meet outlook BTS reiterated its FY outlook of better earnings in 2...
Q2e: continued sales growth We expect sales of SEK 35m, up 9% y-o-y (+7% org.
Relais reported Q2 adjusted EBITA of EUR 7.3m, 13% above LSEG Data & Analytics consensus.
Yesterday, August 14, Verrica presented its top line results from the phase II study of LTX-315 in b...
Redeye was positively surprised by the sales that were better than expected in the quarter.
Redeye updates on EG7 following its Q2-results which were in line with preliminary results.
Ascelia’s actual 21 result is minor compared with the recent SPARKLE success and the ongoing SEK 105...
Q2'24 results Q2'24 sales came in at SEK 382m (2% below ABGSCe SEK 392m).
Redeye’s initial comments on the Q2 report from Waystream.
